The report provides a detailed analysis essential for establishing an Esmolol production plant. It encompasses all critical aspects necessary for Esmolol production, including the cost of Esmolol production, Esmolol plant cost, Esmolol production costs, and the overall Esmolol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Esmolol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Esmolol is a medication used to quickly control the heart rate in patients with atrial fibrillation or atrial flutter that occurs during or after surgery or in other urgent situations where short-term control of the heart rate with a fast-acting drug is needed. It can also be used to treat a rapid heartbeat that is not caused by a compensatory mechanism, such as exercise or fever, and requires specific intervention. It is a beta-adrenergic blocker that is cardioselective.
The procurement of Esmolol is influenced by its application in the pharmaceutical and medical industries. The use of Esmolol has been demanded more since cases of cardiovascular diseases are rising. For focal atrial tachycardia, Esmolol is an effective emergency drug, especially in patients with an active bronchospasm. Furthermore, because of its brief half-life, Esmolol has been shown to be a reliable and effective medicine for regulating blood pressure during surgery. The medication is also recommended for sinus tachycardia, a condition in which an abnormally fast heartbeat necessitates prompt medical attention, particularly in situations of acute coronary syndrome.
Aortic dissection, acute coronary syndrome, non-ST elevation myocardial infarction, hypertensive emergencies, thyrotoxicosis, refractory ventricular tachycardia, ventricular fibrillation resistant to defibrillation, and mitigating the catecholamine response during electroconvulsive therapy are among the conditions for which this medication is used off-label to manage rate and rhythm, thus increasing its demand. Overall, industrial Esmolol procurement is influenced by its application in the pharmaceutical and medical industries, rising cases of cardiovascular diseases, its off-label uses, fewer side effects, emergency uses, and regulatory approvals.
Raw Material for Esmolol Production
According to the Esmolol production plant project report, the key raw material used in the production of Esmolol includes 4-hydroxybenzaldehyde.
Manufacturing Process of Esmolol
The extensive Esmolol production cost report consists of the following major industrial production process:
- Production from 4-hydroxybenzaldehyde: The production process of Esmolol starts with the Wittig reaction of the starting compound to form an intermediate. The intermediate reacts with Pd/C in ethyl acetate under a hydrogen atmosphere to form another intermediate. The intermediate is treated with epichlorohydrin in the presence of K2CO3 in acetonitrile at reflux condition to form the racemic epoxide of methyl 3-[4-(oxiran-2-ylmethoxy)-phenyl] propanoate. The racemic epoxide is then reacted with Jacobsen catalyst and water to form enantioselective epoxide of the final intermediate. Finally, the compound is reacted with N-isopropyl amine in the presence of water to produce Esmolol.
Esmolol, commercially known as Brevibloc, is a white to off-white crystalline powder having the molecular formula C16H25NO4 and a molecular weight of 295.37 g/mol. It has a water solubility of 0.144 mg/mL. It has a log P value of 1.7. It is usually available in its hydrochloride form. The value of its dissociation constant, pKa, is 14.09. It is a beta-adrenergic blocker used to treat hypertension and perioperative tachycardia, among other forms of tachycardia, by temporarily regulating heart rate and ventricular rhythm.
